SVA:NASDAQ
Sinovac Biotech Ltd
6,47 $
0,00%
(0,00) 1 pv
22.2., 17.00.01 UTC-4 · USD
search
Kaikki symbolit
1 pv
5 pv
1 kk
6 kk
YTD
1 v
5 v
MAKS
| Symboli | Hinta | Muutos | Muutos (%) |
|---|
insights_autoLuodaan huippuvinkkejä: SVA…
Volyymi
0,00
52 viikon ylin
28,18 $
52 viikon alin
22,40 $
Liikkeellä olevat osakkeet
59,32 milj.
Työntekijöiden lukumäärä
3 t.
Uutiset
Eri verkkolähteistä
Simply Wall Street
·
38 minuuttia sitten
Should LKQ’s (LKQ) Mega-Yard Expansion and EPS Target Require Action From Investors?
Yahoo Finance
·
5 tuntia sitten
The Best Artificial Intelligence (AI) Growth Stock on the Nasdaq That Morningstar Says Is Still Undervalued
CNBC
·
13 tuntia sitten
Berkshire attracts interest as it slips further behind the S&P 500
PR Newswire
·
1 päivä sitten
Rock Tech Lithium Announces Plans to Dual-List on NASDAQ and Filing of Short Form Base Shelf Prospectus
Profiili
Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a promotional social media astroturfing campaign by the Chinese government. Wikipedia
Tietoa: Sinovac Biotech Ltd
ToimitusjohtajaWeidong Yin
Työntekijät3,04 t.
Perustamispäivä2001
Päätoimipaikka-
Toimiala-
Sivustosinovac.com
Tekoälyn luoma sisältö voi sisältää virheitä. Lue lisää